MS News: April 2014

Research results

  1. Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human
    7thSpace Interactive (press release) – The pathological hallmark of multiple sclerosis (MS) is myelin phagocytosis. It remains unclear why microglia and macrophages demyelinate axons in …
  2. Textured insoles could be a positive step for people with MS
    UQ News – University of Queensland research is investigating the effects textured shoe insoles have on walking problems associated with multiple sclerosis.
  3. ANP reports positive results from chronic toxicity study of ATL1102 in multiple sclerosis – Antisense Therapeutics Limited (“ANP” or the “Company”) is pleased to advise that results from a chronic toxicity study in monkeys indicate that …

Clinical trials

  1. Umbilical Cord Stem Cell Therapy Clinical Trial for Multiple Sclerosis Gets Green Light
    PR Web (press release) – According to the US National Multiple Sclerosis Society, in Multiple Sclerosis (MS), an abnormal immune-mediated T cell response attacks the myelin …
  2. MS and HIV: Could MS Be Caused by a Retrovirus?
    Healthline – Two new studies are under way to test antiretroviral medications on multiple sclerosis (MS) patients.

FDA/NICE updates

  1. Alemtuzumab (Lemtrada) – NICE says yes in final draft guidance
    MS Trust – NICE has announced it intends to recommend alemtuzumab for adults with active relapsing remitting multiple sclerosis. NICE (the National Institute for …
  2. UK’s NICE says “yes” to Genzyme’s MS drug Lemtrada
    The Pharma Letter – The NICE is appraising alemtuzumab as a treatment for adults with relapsing–remitting multiple sclerosis, a chronic and disabling neurological …
  3. Genzyme to Resubmit Lemtrada(TM) Application for FDA Review
    Wall Street Journal – With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve.
  4. NICE likely to back use of IV drug for multiple sclerosis
    Nursing Times – An intravenous drug that is taken once a year over two years looks set to gain official approval as a new treatment option for multiple sclerosis

Medical treatment news

  1. New Clues to Link Between MS Drug Tysabri and Rare Brain Disease – A combination of three factors seems to put MS patients at highest risk: treatment with Tysabri for more than two years; receiving other kinds of …
  2. Cambridge technology in Novartis auto-injector for…
    Business Weekly – Big Pharma giant Novartis is using medical technology expertise from Cambridge UK for a new auto-injector for sufferers of multiple sclerosis.
  3. Generic Multiple Sclerosis Drug Glatiramer Acetate from Synthon Passes Phase III
    BioNews Texas – Glatiramer Acetate and multiple sclerosis Synthon just released the results of its Phase III GATE study using a generic version of glatiramer acetate.
  4. Neurologists endorse cannabis for MS pain
    6minutes – There is enough evidence for clinicians to prescribe cannabis in pill or spray form to ease patient-reported pain and spasticity in multiple sclerosis, …
  5. Mode of action of new multiple sclerosis drug discovered
    Medical Xpress – Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis. Although its efficacy has been …
  6. Striking a Nerve: Marijuana for MS. Now What?
    MedPage Today – new practice guideline that gave a qualified endorsement to certain cannabis-based products for controlling particular multiple sclerosis symptoms.

News from MS Societies all around the world

  1. Global Partners’ Alltown Convenience Stores, CFMS Donate $300000 to National Multiple
    NACS Online – Global Partners LP’s Alltown convenience stores and the CFMS Fund Foundation Inc. recently donated $300,000 to the National Multiple Sclerosis …
  2. Kessler Foundation awarded $750000 grant from National MS Society for cognitive research
    Phys.Org – West Orange, NJ. April 2, 2014. Kessler Foundation received a four-year $750,000 grant from the National Multiple Sclerosis Society to conduct a …
  3. How charities can empower their service users – a case study
    The Guardian – In order to break down barriers between health experts and people with multiple sclerosis, charity decided to help service users

General news

  1. App helps MS sufferers share realities of disease
    The Canberra Times – Unseen to those who aren’t living them, the symptoms of Multiple Sclerosis have become a little more visible through the help of a creative new …
  2. Kessler Foundation receives MS Research Center Award from National MS Society
    Phys.Org – West Orange, NJ. March 31, 2014. Kessler Foundation is the recipient of a MS Research Center Award from the National Multiple Sclerosis Society.
  3. Dorset nurse Rebecca French first in county to trial new multiple sclerosis drug
    Bournemouth Echo – A 39-YEAR-OLD nurse is the first person in Dorset to trial a ground-breaking new drug that can delay the progress of multiple sclerosis. Rebecca …

Business news

  1. Irish firm to buy fast-growing MS-drug maker Questcor for $5.6 billion
    Los Angeles Times – One of its products is Acthar Gel, which is used in the treatment of multiple sclerosis. The combined company will be based in Dublin with Trudeau as …
  2. Research and Markets: Global Multiple Sclerosis Therapeutics Market 2013-2019 with Copaxone…
    The Herald | (press release) – The Multiple Sclerosis (MS) market has been growing consistently over the last two decades and is forecast to continue to grow from $8.1 billion

©Willeke Van Eeckhoutte and Ireland, MS and Me, 2011-2014. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, MS and Me with appropriate and specific direction to the original content.

4 thoughts on “MS News: April 2014

    1. Thanks! And I agree, some of them also baffle me still, plus I can’t get used to the generic names of medication as it’s used far more by doctors and such. As a patient I can only remember the brand names :D

Your thoughts?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.